Lynwood Capital Management Inc. - IMMIX BIOPHARMA INC ownership

Back to all holdings Add to watchlist

IMMIX BIOPHARMA INC's ticker is and the CUSIP is 45258H106. A total of 12 filers reported holding IMMIX BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
Quarter-by-quarter ownership
Lynwood Capital Management Inc. ownership history of IMMIX BIOPHARMA INC
ValueSharesWeighting
Q2 2023$538,673
+928646.6%
200,250
+701.0%
0.68%
+874.3%
Q4 2022$58
-100.0%
25,000
-95.6%
0.07%
-96.4%
Q4 2021$2,012,000–565,297–1.92%–
 Download
Other shareholders
IMMIX BIOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
XTX Topco Ltd 12,992$31,0000.01%
Virtu Financial LLC 23,515$57,0000.00%
InterOcean Capital Group, LLC 15,900$38,0000.00%
WELLS FARGO & COMPANY/MN 26$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
BlackRock Inc. 9,415$22,0000.00%
Citadel Advisors 21,713$52,0000.00%
Renaissance Technologies 62,600$151,0000.00%
OSAIC HOLDINGS, INC. 350$1,0000.00%
View complete list of IMMIX BIOPHARMA INC shareholders